| |
| |
|
| Insider
Information: |
Norby R Douglas |
| Relationship: |
Director |
| City: |
San Jose |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
64,629 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,417,365 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
64,629 |
|
|
| Total
Value |
$2,417,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tessera Technologies Inc |
TSRA |
Officer |
2006-01-11 |
19,703 |
2004-12-21 |
0 |
Premium* |
|
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-05-10 |
4,906 |
2006-01-09 |
0 |
Premium* |
|
|
Ikanos Communications |
IKAN |
Director |
2012-10-31 |
9,000 |
2012-10-31 |
0 |
Premium* |
|
|
Magnachip Semiconductor Corp |
MX |
Director |
2016-03-11 |
22,020 |
2015-06-09 |
0 |
Premium* |
|
|
Krystal Biotech Inc |
KRYS |
Director |
2018-05-09 |
9,000 |
2018-05-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRYS |
Krystal Biotech Inc |
Director |
– • – |
2018-05-09 |
4 |
B |
$10.42 |
$93,780 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2017-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,030 |
4,906 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-09-23 |
4 |
OE |
$128.81 |
$2,014,105 |
D/D |
15,500 |
2,876 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2016-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
18,376 |
0 |
- |
|
| MX |
Magnachip Semiconductor C... |
Director |
– • – |
2016-03-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,314 |
22,020 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
S |
$186.97 |
$8,530,124 |
D/D |
(45,442) |
32,481 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-12-11 |
4 |
A |
$16.83 |
$1,535,039 |
D/D |
45,442 |
77,923 |
0 |
- |
|
| MX |
Magnachip Semiconductor C... |
Director |
– • – |
2015-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
15,706 |
15,706 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2015-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
32,481 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2014-02-28 |
4 |
A |
$0.00 |
$0 |
D/D |
895 |
32,676 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-10-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,363 |
31,781 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-05-22 |
4 |
S |
$100.11 |
$4,110,712 |
D/D |
(40,000) |
56,144 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-05-22 |
4 |
OE |
$10.84 |
$555,490 |
D/D |
40,000 |
96,144 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2013-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,471 |
56,144 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-12-10 |
4 |
OE |
$4.93 |
$149,830 |
D/D |
22,000 |
60,673 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2012-12-10 |
4 |
S |
$93.00 |
$2,046,000 |
D/D |
(22,000) |
38,673 |
0 |
- |
|
| IKAN |
Ikanos Communications |
Director |
– • – |
2012-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
9,000 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-14 |
4 |
S |
$89.93 |
$2,068,390 |
D/D |
(23,000) |
13,814 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-14 |
4 |
OE |
$5.37 |
$170,910 |
D/D |
23,000 |
36,814 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2011-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,725 |
13,814 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2010-01-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,965 |
15,054 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-11-03 |
4 |
OE |
$7.79 |
$116,850 |
D/D |
15,000 |
26,089 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-11-03 |
4 |
AS |
$43.74 |
$659,064 |
D/D |
(15,000) |
11,089 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-08-04 |
4 |
AS |
$45.00 |
$90,000 |
D/D |
(2,000) |
11,089 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Director |
– • – |
2009-08-04 |
4 |
OE |
$42.06 |
$84,120 |
D/D |
2,000 |
13,089 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
